XML 21 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares [Member]
MCPS [Member]
 [1]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Shares [Member]
Total Teva Shareholders' Equity [Member]
Non-controlling Interests [Member]
Beginning balance at Jan. 06, 2016 $ 29,927 $ 52 $ 3,291 $ 17,757 $ 14,851 $ (1,955) $ (4,227) $ 29,769 $ 158
Beginning balance, shares at Jan. 06, 2016   1,016              
Comprehensive income (loss) (953)       329 (1,204)   (875) (78)
Ordinary shares issuance, value [2] 5,391 $ 2   5,389       5,391  
Ordinary shares issuance, shares [2]   106              
MCPS issuance [2] 329   329         329  
Exercise of options by employees and vested RSUs, value 35     2     33 35  
Exercise of options by employees and vested RSUs, shares   1              
Stock-based compensation expense 159     159       159  
Dividends to ordinary shareholders (1,303)       (1,303)     (1,303)  
Accrued dividends to preferred shareholders (261)       (261)     (261)  
Transactions with non-controlling interests 1,684     111       111 1,573
Other (15)     (9) (9)     (18) 3
Ending balance at Dec. 31, 2016 34,993 $ 54 3,620 23,409 13,607 (3,159) (4,194) 33,337 1,656
Ending balance, shares at Dec. 31, 2016   1,123              
Comprehensive income (loss) (15,080)       (16,265) 1,306   (14,959) (121)
Exercise of options by employees and vested RSUs, value   $ 0 [3]   (45)     45    
Exercise of options by employees and vested RSUs, shares   1              
Stock-based compensation expense 133     133       133  
Dividends to ordinary shareholders (901)       (901)     (901)  
Accrued dividends to preferred shareholders (249)   11 (11) (249)     (249)  
Transactions with non-controlling interests (111)               (111)
Other (40)     (7) 5     (2) (38)
Ending balance at Dec. 31, 2017 18,745 $ 54 3,631 23,479 (3,803) (1,853) (4,149) 17,359 1,386
Ending balance, shares at Dec. 31, 2017   1,124              
Cumulative effect of new accounting standard (See Note 1)         (5) 5      
Comprehensive income (loss) (3,057)       (2,150) (611)   (2,761) (296)
Ordinary shares issuance, value [4] (52) $ 2 (3,880) 3,826       (52)  
Issuance of Treasury Shares 4     (3)     7 4  
Ordinary shares issuance, shares [4]   72              
Stock-based compensation expense 155     155       155  
Accrued dividends to preferred shareholders     $ 249 (249)          
Transactions with non-controlling interests (1)     2       2 (3)
Ending balance at Dec. 31, 2018 $ 15,794 $ 56   $ 27,210 $ (5,958) $ (2,459) $ (4,142) $ 14,707 $ 1,087
Ending balance, shares at Dec. 31, 2018   1,196              
[1] Mandatory convertible preferred shares.
[2] Net of issuance costs.
[3] Represents an amount less than 0.5 million.
[4] Mainly MCPS conversion, net of tax withholding.